Thoughts on Healthcare Markets & Tech

Thoughts on Healthcare Markets & Tech

Publication
0 followers

Strategy & investing

How Claude Mythos Preview Found Thousands of Zero-Day Vulnerabilities and Why the Health Tech Sector’s Absence From Project Glasswing Should...
NewsApr 13, 2026

How Claude Mythos Preview Found Thousands of Zero-Day Vulnerabilities and Why the Health Tech Sector’s Absence From Project Glasswing Should...

On April 7, 2026 Anthropic unveiled Claude Mythos Preview, an AI model that autonomously discovered thousands of zero‑day vulnerabilities across major operating systems and browsers. The company kept the model private and launched Project Glasswing, a defensive coalition of 40+...

By Thoughts on Healthcare Markets & Tech
The PCP as Specialist: How AI and Virtual Consults Will Collapse the Referral Economy and Create a New Category of...
NewsApr 12, 2026

The PCP as Specialist: How AI and Virtual Consults Will Collapse the Referral Economy and Create a New Category of...

The essay proposes an AI‑driven platform that lets primary‑care physicians (PCPs) handle many conditions traditionally referred to specialists, using an asynchronous eConsult loop. Roughly 9% of PCP visits generate referrals, costing about $965 each, and half never result in completed...

By Thoughts on Healthcare Markets & Tech
NVIDIA Just Helped Map 31 Million Protein Complexes and the Health Tech Investment Implications Are Enormous
NewsApr 10, 2026

NVIDIA Just Helped Map 31 Million Protein Complexes and the Health Tech Investment Implications Are Enormous

NVIDIA, DeepMind, EMBL‑EBI and Seoul National University expanded the AlphaFold Protein Structure Database to include 31 million predicted protein complexes—23.4 million homodimers and 7.6 million heterodimers—across 4,777 proteomes. Using H100 DGX Superpod clusters, MMseqs2‑GPU and TensorRT‑accelerated inference, the team generated 1.8 million high‑confidence homodimer...

By Thoughts on Healthcare Markets & Tech
From Fringe to Formulary: How Integrative Medicine, Peptides, and the D2C Biomarker Stack Are Reshaping the Boundaries of Evidence-Based Care
NewsApr 9, 2026

From Fringe to Formulary: How Integrative Medicine, Peptides, and the D2C Biomarker Stack Are Reshaping the Boundaries of Evidence-Based Care

Integrative health, once a fringe market, now commands a $30 billion out‑of‑pocket industry with 37 % of U.S. adults spending on modalities like acupuncture, functional‑medicine and peptide protocols. Federal agencies are building measurement tools—NIH’s NCCIH $170 M Whole Person Health Index—and the VA’s...

By Thoughts on Healthcare Markets & Tech
The BALANCE Model, GLP-1 Coverage, and the Peptide Regulatory Collision: What Every Health Tech Operator and Investor Needs to Know...
NewsApr 8, 2026

The BALANCE Model, GLP-1 Coverage, and the Peptide Regulatory Collision: What Every Health Tech Operator and Investor Needs to Know...

CMS launched the BALANCE Model, a voluntary 1115A demonstration that waives the Part D exclusion on weight‑loss drugs and negotiates a net price of $245 per month for GLP‑1s such as Zepbound, Ozempic and Wegovy. To trigger a Medicare rollout...

By Thoughts on Healthcare Markets & Tech
The CY 2027 MA Rate Announcement as an Entrepreneur’s Prospectus
NewsApr 7, 2026

The CY 2027 MA Rate Announcement as an Entrepreneur’s Prospectus

CMS released the CY 2027 Medicare Advantage and Part D rate announcement on April 6, 2026, confirming a 2.48% net average payment increase—about $13 billion more than 2026. Beyond the headline, the rule introduces several operational mandates: unlinked chart‑review diagnoses are excluded from...

By Thoughts on Healthcare Markets & Tech
Yuzu Health, General Catalyst, and the Quiet Bet on Health Insurance Plumbing
NewsApr 6, 2026

Yuzu Health, General Catalyst, and the Quiet Bet on Health Insurance Plumbing

Yuzu Health announced a $35 million Series A round co‑led by General Catalyst and Chemistry, bringing total capital to $40 million. The startup operates a vertically integrated third‑party administrator (TPA) that has built its entire software stack in‑house, processing over $1 billion in claims...

By Thoughts on Healthcare Markets & Tech
The Peptide Economy vs the Healthcare AI Economy: Which Side of the Trade Matters More
NewsApr 5, 2026

The Peptide Economy vs the Healthcare AI Economy: Which Side of the Trade Matters More

The essay contrasts the rapidly expanding peptide economy—led by GLP‑1 and next‑generation obesity drugs—with the burgeoning healthcare‑AI sector, arguing they are interdependent rather than competing. Peptide revenues are projected to surpass $200 billion annually by 2030, while AI revenues sit at...

By Thoughts on Healthcare Markets & Tech
The Hospice Industries Fraud Crisis Just Got a Reckoning: Reading the FY 2027 CMS Proposed Rule Against the Backdrop of...
NewsApr 4, 2026

The Hospice Industries Fraud Crisis Just Got a Reckoning: Reading the FY 2027 CMS Proposed Rule Against the Backdrop of...

CMS released a FY 2027 hospice wage index and payment rate update proposing a 2.4% increase that would add roughly $785 million in Medicare payments. The rule arrives days after the Operation Never Say Die arrests, which uncovered a $60 million fraud ring...

By Thoughts on Healthcare Markets & Tech
The $1.8B Ozempic Middleman and What It Actually Means for Health Tech
NewsApr 3, 2026

The $1.8B Ozempic Middleman and What It Actually Means for Health Tech

Medvi, a two‑person GLP‑1 telehealth brand, posted $401 million in 2025 revenue and is on track for $1.8 billion in 2026, delivering a 16.2% net margin. The company built its consumer‑facing platform using AI tools for under $20,000, while outsourcing all clinical...

By Thoughts on Healthcare Markets & Tech
What the Leaked Claude Code Codebase Tells Healthcare Builders About Designing Agentic Health Tech
NewsApr 2, 2026

What the Leaked Claude Code Codebase Tells Healthcare Builders About Designing Agentic Health Tech

On March 31, 2026 a 59.8 MB source‑map file unintentionally exposed Anthropic’s Claude Code TypeScript codebase, revealing roughly 512,000 lines of production‑grade AI agent logic. The leak showcases a three‑layer skeptical memory system, a coordinator mode for multi‑agent orchestration, the AutoDream consolidation...

By Thoughts on Healthcare Markets & Tech
NVIDIA’s Healthcare Stack Is the Picks and Shovels Play You’ve Been Waiting For
NewsMar 31, 2026

NVIDIA’s Healthcare Stack Is the Picks and Shovels Play You’ve Been Waiting For

NVIDIA has assembled a comprehensive AI infrastructure stack for healthcare, encompassing BioNeMo, MONAI, Isaac for Healthcare, Holoscan, Parabricks, Clara and NIM. Its 2026 State of AI in Healthcare survey shows 70% of organizations actively using AI, with generative models now...

By Thoughts on Healthcare Markets & Tech
The Unfair Advantage Nobody Talks About: How Skipping BAAs Unlocks Venture-Scale Growth in Health Tech
NewsMar 29, 2026

The Unfair Advantage Nobody Talks About: How Skipping BAAs Unlocks Venture-Scale Growth in Health Tech

The essay argues that health‑tech firms that avoid HIPAA’s Business Associate Agreement (BAA) can scale like consumer software, unlocking venture‑scale growth. OpenEvidence exemplifies this model, leaping from zero to $50 million ARR, then $150 million ARR, and a $12 billion valuation in about...

By Thoughts on Healthcare Markets & Tech
The MATCH Monopoly and What It Actually Means for Health Tech
NewsMar 28, 2026

The MATCH Monopoly and What It Actually Means for Health Tech

Congressional scrutiny of the National Resident Matching Program’s (NRMP) antitrust exemption intensified after a May 2025 hearing, highlighting wage suppression and a persistent residency bottleneck. In 2025, 52,498 medical students competed for 43,237 slots, leaving roughly 9,000 unmatched, while average...

By Thoughts on Healthcare Markets & Tech
Thoughts on Healthcare Markets & Tech | Pulse